ATE448309T1 - Luziferase expressionskassetten und methoden zu ihrer verwendung - Google Patents

Luziferase expressionskassetten und methoden zu ihrer verwendung

Info

Publication number
ATE448309T1
ATE448309T1 AT06009933T AT06009933T ATE448309T1 AT E448309 T1 ATE448309 T1 AT E448309T1 AT 06009933 T AT06009933 T AT 06009933T AT 06009933 T AT06009933 T AT 06009933T AT E448309 T1 ATE448309 T1 AT E448309T1
Authority
AT
Austria
Prior art keywords
methods
luciferase expression
expression cassettes
cassettes
conferring
Prior art date
Application number
AT06009933T
Other languages
English (en)
Inventor
Kevin P Francis
Pamela R Contag
Danny J Joh
Original Assignee
Xenogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenogen Corp filed Critical Xenogen Corp
Application granted granted Critical
Publication of ATE448309T1 publication Critical patent/ATE448309T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1051Gene trapping, e.g. exon-, intron-, IRES-, signal sequence-trap cloning, trap vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/65Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0069Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/66Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AT06009933T 1999-09-08 2000-09-07 Luziferase expressionskassetten und methoden zu ihrer verwendung ATE448309T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15290499P 1999-09-08 1999-09-08

Publications (1)

Publication Number Publication Date
ATE448309T1 true ATE448309T1 (de) 2009-11-15

Family

ID=22544956

Family Applications (2)

Application Number Title Priority Date Filing Date
AT00960044T ATE331790T1 (de) 1999-09-08 2000-09-07 Luziferase expressionskassetten und methoden zu ihrer verwendung
AT06009933T ATE448309T1 (de) 1999-09-08 2000-09-07 Luziferase expressionskassetten und methoden zu ihrer verwendung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT00960044T ATE331790T1 (de) 1999-09-08 2000-09-07 Luziferase expressionskassetten und methoden zu ihrer verwendung

Country Status (8)

Country Link
EP (2) EP1728866B1 (de)
JP (2) JP4669180B2 (de)
AT (2) ATE331790T1 (de)
AU (1) AU779263B2 (de)
CA (1) CA2384496A1 (de)
DE (2) DE60029107T2 (de)
ES (1) ES2267561T3 (de)
WO (1) WO2001018195A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7255851B2 (en) 1994-07-01 2007-08-14 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive localization of a light-emitting conjugate in a mammal
US6217847B1 (en) 1994-07-01 2001-04-17 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive localization of a light-emitting conjugate in a mammal
ATE341637T1 (de) 1998-12-17 2006-10-15 Xenogen Corp Unblutige bestimmung einer physiologischen reaktion in einem säugetier
US6610503B1 (en) 1999-03-17 2003-08-26 Xenogen Corporation Animal models for predicting sepsis mortality
US6737245B1 (en) 1999-09-08 2004-05-18 Xenogen Corporation Luciferase expression cassettes and methods of use
US6867348B1 (en) 1999-12-16 2005-03-15 Xenogen Corporation Methods and compositions for screening for angiogenesis modulating compounds
IT1311335B1 (it) 1999-12-21 2002-03-12 Otc Optical Technologies Ct S Procedimento e dispositivo per realizzare reticoli in fibra ottica.
US7056728B2 (en) 2000-07-06 2006-06-06 Xenogen Corporation Compositions and methods for use thereof in modifying the genomes of microorganisms
US6858773B2 (en) 2001-04-20 2005-02-22 Xenogen Corporation Transgenic mice comprising transcription control elements associated with mouse eosinophil peroxidase expression
CN1738649A (zh) * 2001-07-09 2006-02-22 抗癌公司 用荧光蛋白作为标记物使感染成像
EP1281772A1 (de) * 2001-07-31 2003-02-05 Aladar A. Szalay Lichtemittierende Mikroorganismen und Zellen zum Nachweis und zur Therapie von Krebs
EP1281767A3 (de) * 2001-07-31 2003-05-28 Aladar A. Szalay Lichtausstrahlende Mikroorganismen und Zellen für die Diagnose und Therapie von Tumoren
WO2005047458A2 (en) 2003-06-18 2005-05-26 Genelux Corporation Modified recombinant vaccina viruses and other microorganisms, uses thereof
WO2008100292A2 (en) 2006-10-16 2008-08-21 Genelux Corporation Modified vaccinia virus strains for use in diagnostic and therapeutic methods
WO2008109459A1 (en) 2007-03-02 2008-09-12 University Of Massachusetts Luciferins
WO2015031859A1 (en) * 2013-08-29 2015-03-05 The Regents Of The University Of California Bacteria engineered for ester production
EP3976116A4 (de) 2019-05-30 2023-08-23 490 Biotech, Inc. Lux-expression in zellen und verfahren zur verwendung
CN110295181B (zh) * 2019-06-18 2022-10-11 山东大学 一种利用生物发光报告系统鉴定抗生素种类的方法
DE102020129009A1 (de) 2020-11-04 2022-05-05 Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen, Körperschaft des öffentlichen Rechts Nachweis von umwelteinflüssen mittels biolumineszenz
CN113403243B (zh) * 2021-06-16 2022-07-19 中国人民解放军军事科学院军事医学研究院 基于lux报告系统的猪链球菌发光菌及其构建方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0798384A1 (de) * 1992-10-02 1997-10-01 Lonza A.G. Biotechnologisches Verfahren zur Herstellung von Biotin
FI96697C (fi) * 1993-08-18 2001-05-16 Valio Oy Uudet Streptococcus thermophilus -kannat ja niiden käyttö antibioottie n määrittämiseen
WO1999014311A1 (en) * 1997-09-18 1999-03-25 Smithkline Beecham Corporation Method of screening for antimicrobial compounds

Also Published As

Publication number Publication date
EP1728866B1 (de) 2009-11-11
DE60043321D1 (de) 2009-12-24
ES2267561T3 (es) 2007-03-16
AU7126600A (en) 2001-04-10
JP4669180B2 (ja) 2011-04-13
AU779263B2 (en) 2005-01-13
CA2384496A1 (en) 2001-03-15
JP2011041577A (ja) 2011-03-03
WO2001018195A3 (en) 2001-06-21
ATE331790T1 (de) 2006-07-15
EP1728866A2 (de) 2006-12-06
JP5295206B2 (ja) 2013-09-18
DE60029107D1 (de) 2006-08-10
EP1212429A2 (de) 2002-06-12
EP1728866A3 (de) 2007-03-14
EP1212429B1 (de) 2006-06-28
JP2003509029A (ja) 2003-03-11
DE60029107T2 (de) 2007-01-11
WO2001018195A2 (en) 2001-03-15

Similar Documents

Publication Publication Date Title
DE60029107D1 (de) Luziferase expressionskassetten und methoden zu ihrer verwendung
DE69535037D1 (de) Mikrobielle transglutaminasen, ihre herstellung und ihre verwendung
SE9900100D0 (sv) New compounds
DE69730820D1 (de) Polyazomacrocyclofluoromonoalkylphosphensäure, ihre komplexe zur verwendung als kontrastmittel
DE60330841D1 (de) Überexpression von extremozymgenen in pseudomonas und nahe verwandte bakterien
EP0576870A3 (de) Kulturvorrichtung für Mikroorganismen.
TR200102773T2 (tr) Alkoksisilan yapısal birimleri olan poliüretan eriyikleri
CY1106984T1 (el) Νεα βιοσυγκολλητικη συνθεση που περιεχει μια βιοσυγκολλητικη πολυφαινολικη πρωτεϊνη, ενα πολυμερες που περιεχει ομαδες υδατανθρακα, φαρμακευτικως αποδεκτα λεπτα νηματα και οι χρησεις τους
DE69633679D1 (de) Substituierte aryl-oder heteroarylamide mit retinoid-ähnlicher biologischer aktivität
DE69928952D1 (de) Chinolin-derivate und ihre verwendung als antibakterielle wirkstoffe
YU19499A (sh) Benzonaftiridini kao bronhijalni terapeutici
ATE256677T1 (de) Inhibitoren der bakteriellen nad synthetase
FR15C0027I1 (de)
CY1111775T1 (el) Πνευμονικα κυτταρα βαμβακοαρουραιου για καλλιεργεια ιου
PL378054A1 (pl) Sposób wykrywania Escherichia coli
NO992092D0 (no) FremgangsmÕte for deteksjon av ikke-patogene bakteriestammer
DE3765853D1 (de) Hydroxipyrazol-derivate- verfahren zu ihrer herstellung und ihre verwendung gegen mikroorganismen.
TR199901386T2 (en) �midazopiridazinler.
DE69530577D1 (de) Mikrobiologische kulturflaschen, ihre herstelling und verwendung
WO2001057533A3 (en) Detection and differentiation of bacteria using electrical detection methods
ATE382620T1 (de) Pyrano, piperidino, und thiopyrano derivate und methode zur verwendung
ATE225859T1 (de) Nachweis von antibiotikumresistenzen in mikroorganismen
DK0705904T3 (da) Luminescerende nitrificerende mikroorganismer
EE04944B1 (et) Bakteriaalsed plasmiidid kasutamiseks ekspressioonivektoritena v?i mikrobioloogilisel analsil
MY132876A (en) Method for visually demonstrating the effectiveness of an anti-bacteria attachment composition

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties